Figure 2. Psoriatic lesions of patient 2.
( a– d) Psoriatic lesions of second patient before treatment with brodalumab. ( e– h) Psoriatic lesions of second patient after treatment with brodalumab.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.